Westfield Group needs to add more sugar

Based on today's terms, the proposal is unlikely to gather enough support.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Based on today's terms, the deal to restructure the Westfield businesses won't make it off the ground.

Although shopping centre giant Westfield Group (ASX: WDC) and its affiliate Westfield Retail Trust (ASX: WRT) have both expressed their confidence that their merger proposal will achieve the required 75% approval rate, investors are not so convinced.

The deal, which would see the Group's and Trust's domestic assets merged to form Scentre Group (while the Group's international assets would be spun off into a separate entity), has received significant opposition given a merger ratio which WRT investors deem to be unfair. They claim that the $1.8 billion in costs for management rights and development rights is excessive and have been pushing for the deal to be sweetened in their favour (in fact, some investors want almost $1 billion of the costs removed).

Citing a strengthening Australian division however, Westfield said that the deal was fair. The Group's joint CEO Peter Lowy said the transaction would "move ahead on the terms announced on December 4" while the Trust's managing director Domenic Panaccio said the "deal would get through".

Equity broker CLSA recently predicted that 15% of investors would oppose the deal based on its current terms if the vote was held today. UniSuper, for instance, holds 7% of the Trust's shares and is opposing the deal. While 15% is a significant portion, investors are suggesting that number is likely to be much higher.

Foolish takeaway

At today's prices, both corporations are looking attractive. WRT's shares are trading at $3.08 (3% higher since the deal was announced) while the Group's are priced at $10.37 (3.8% down since the announcement). The performance of the shares over the last three months indicates the market is also expecting the deal to be given more weighting in WRT's favour.

With the explanatory memorandum and an independent expert's report due to be released sometime in April, greater transparency will be provided, which will start to shed more light on the scenario.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »